Brokerages Set DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Target Price at $33.44

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has earned an average recommendation of “Moderate Buy” from the eleven brokerages that are covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $33.44.

Several analysts recently issued reports on XRAY shares. Barrington Research reiterated an “outperform” rating and set a $38.00 target price on shares of DENTSPLY SIRONA in a report on Monday, July 8th. Needham & Company LLC reissued a “buy” rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Stifel Nicolaus lowered their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating on the stock in a report on Thursday, July 18th. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, Evercore ISI decreased their price objective on shares of DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 9th.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $24.73 on Friday. The firm’s 50 day moving average price is $25.35 and its two-hundred day moving average price is $28.23. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.87 and a current ratio of 1.33. DENTSPLY SIRONA has a twelve month low of $23.58 and a twelve month high of $37.60. The firm has a market cap of $5.13 billion, a P/E ratio of -56.20, a PEG ratio of 1.23 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 EPS for the quarter, missing the consensus estimate of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same quarter in the previous year, the company posted $0.51 EPS. The business’s revenue for the quarter was down 4.3% compared to the same quarter last year. On average, analysts forecast that DENTSPLY SIRONA will post 1.99 EPS for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be issued a $0.16 dividend. The ex-dividend date is Friday, September 27th. This represents a $0.64 annualized dividend and a yield of 2.59%. DENTSPLY SIRONA’s dividend payout ratio is currently -145.45%.

Institutional Trading of DENTSPLY SIRONA

Hedge funds have recently added to or reduced their stakes in the company. Sanctuary Advisors LLC acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth about $481,000. Teachers Retirement System of The State of Kentucky increased its holdings in shares of DENTSPLY SIRONA by 264.5% during the second quarter. Teachers Retirement System of The State of Kentucky now owns 70,598 shares of the medical instruments supplier’s stock worth $1,758,000 after purchasing an additional 51,228 shares during the period. Brandes Investment Partners LP raised its position in shares of DENTSPLY SIRONA by 102.7% in the second quarter. Brandes Investment Partners LP now owns 46,638 shares of the medical instruments supplier’s stock valued at $1,166,000 after buying an additional 23,626 shares in the last quarter. Creative Planning grew its position in DENTSPLY SIRONA by 53.9% during the second quarter. Creative Planning now owns 16,540 shares of the medical instruments supplier’s stock worth $412,000 after buying an additional 5,793 shares in the last quarter. Finally, Algert Global LLC increased its stake in DENTSPLY SIRONA by 123.9% during the 2nd quarter. Algert Global LLC now owns 32,083 shares of the medical instruments supplier’s stock worth $799,000 after acquiring an additional 17,753 shares during the period. 95.70% of the stock is owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.